Rich nations vaccinating 1 person per second, but most poorer ones haven’t given a single shot, watchdog says

People queue in vehicles as they arrive for vaccinations at California State University of Los Angeles on March 4.
People queue in vehicles as they arrive for vaccinations at California State University of Los Angeles on March 4. Frederic J. Brown/AFP/Getty Images

Rich countries are vaccinating one person every second against Covid-19 while the majority of their poorest counterparts have yet to administer a single dose, the People’s Vaccine Alliance said Tuesday. 

These same rich nations are blocking efforts by developing countries to waive intellectual property rights on Covid-19 vaccines, the alliance said. The World Trade Organization’s Trade-Related Aspects of Intellectual Property (TRIPS) committee meets Wednesday to discuss the TRIPS waiver.

“We should act now. There is no going back. It is totally unfair that rich countries, who have enough vaccines to protect their citizens, are blocking the TRIPS waiver, which could help poorer countries get the vaccines they need,” said Muhammad Yunus, Nobel laureate professor, and one of the leaders of the People’s Vaccine Alliance.
“For the rich world, this proposed act of human solidarity to ensure that medicines and vaccines get to the whole human family simultaneously is in their own self-interest, not just an act of charity,”

The People’s Vaccine Alliance, a group of organizations including Oxfam International, Frontline AIDS, UNAIDS, and others, says this is yet another example of rich countries prioritizing the interests of big pharmaceutical monopolies over people’s lives. 

“By allowing a small group of pharmaceutical companies to decide who lives and who dies, rich nations are prolonging this unprecedented global health emergency and putting countless more lives on the line,” said Oxfam’s executive director Gabriela Bucher.

“At this crucial time, developing countries need support – not opposition.” 

The proposed TRIPS wavier would remove legal barriers and allow manufacturers across the world to start producing vaccines at scale within months, the alliance said. 

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *